Stay updated on Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a small software update to the page without changing visible content.
    Difference
    0.1%
    Check dated 2026-05-15T02:14:17.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer now displays Revision: v3.5.3, signaling a new software release for the ClinicalTrials.gov page. This update is a release-level change and does not change the visible content or functionality of the page.
    Difference
    0.1%
    Check dated 2026-04-30T16:27:50.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and deleted Revision: v3.5.0. This reflects a minor version update on the page.
    Difference
    0.1%
    Check dated 2026-04-16T10:30:19.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.3 to v3.5.0. This is a minor technical update reflecting the latest site version.
    Difference
    0.1%
    Check dated 2026-03-18T16:58:52.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. This reflects a minor site update.
    Difference
    0.1%
    Check dated 2026-03-11T14:26:05.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the site, and the lapse funding notice along with the prior Revision: v3.4.1 reference were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-02-11T04:42:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.